abstract |
The present invention is an NSAIDs-based drug, solubilizing water-soluble zaltoprofen as an active ingredient, using a self-emulsifying emulsion system containing a hydrophilic solvent, a pH adjuster, a surfactant, an oil, and so on, and then filling the soft capsule with a bioabsorption rate. The present invention relates to a soft capsule containing zaltoprofen, which is greatly improved and ensures stability. |